Hemoperfusion Clinical Trial
Official title:
Hemoperfusion in Combination With Hemodialysis for Improvement of Self-reported Sleep Disturbance and Overall Survival Rate in Maintenance Hemodialysis Patients
| Verified date | March 2018 |
| Source | Shanghai Pudong Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Sleep disturbance has been long-standing torments in most of patients with maintenance hemodialysis (HD). In this study, we attempted to explore whether long-term hemoperfusion (HP) could improve sleep disorder and increase overall survival rate in HD patients.
| Status | Completed |
| Enrollment | 156 |
| Est. completion date | December 1, 2017 |
| Est. primary completion date | August 1, 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 80 Years |
| Eligibility |
Inclusion Criteria: 1. duration of maintenance HD should be equal or more than 3 months, 2. patient's age should be equal or more than 18 years Exclusion Criteria: - i) he/she diagnosed with malignant tumors, an active rheumatism, infectious diseases, or a severe heart failure ii) he/she would disagree with the study 3. he/she has received a short-term poor prognosis 4. he/she would be more than 80 years old |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Shanghai Pudong Hospital |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | improvement of self-reported sleep disturbance | Analysis of the sleep disturbance by using Pittsburgh Sleep Quality Index (PSQI) questionnaire | 2 years | |
| Secondary | survival | increase overall survival rate | 2 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04643639 -
Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis
|
Phase 3 | |
| Not yet recruiting |
NCT05044403 -
Evaluation of the Efficacy and Safety of Extracorporeal Support With Hemoperfusion in Critical Patients With Multiorgan Dysfunction Syndrome by Septic Origin
|
Phase 4 | |
| Completed |
NCT02461953 -
Combination of Hemodialysis With Hemoperfusion:A Clinical Study
|
N/A |